How big is the Human Microbiome Market?

The Human Microbiome Market size is expected to reach USD 0.90 billion in 2024 and grow at a CAGR of 16.37% to reach USD 1.92 billion by 2029. Read More

What is the current Human Microbiome Market size?

In 2024, the Human Microbiome Market size is expected to reach USD 0.90 billion. Read More

Who are the key players in Human Microbiome Market?

DuPont, Seres Therapeutics, Second Genome, Synthetic Biologics Inc. and Axial Biotherapeutics, Inc. are the major companies operating in the Human Microbiome Market. Read More

Which is the fastest growing region in Human Microbiome Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Human Microbiome Market?

In 2024, the North America accounts for the largest market share in Human Microbiome Market. Read More

What years does this Human Microbiome Market cover, and what was the market size in 2023?

In 2023, the Human Microbiome Market size was estimated at USD 0.77 billion. The report covers the Human Microbiome Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Human Microbiome Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Human Microbiome Market Share

Statistics for the 2023 & 2024 Human Microbiome market share, created by Mordor Intelligence™ Industry Reports. Human Microbiome share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

~~$4750~~

Team License

~~$5250~~

Corporate License

~~$8750~~

Buy Now

Book before:

Market Share of Human Microbiome Industry

The human microbiome market is moderately competitive, and several players are coming up with new products. Companies like Axial Biotherapeutics, Inc, DuPont, Series Therapeutics, Second Genome, and Synthetic Biologics hold substantial shares in the market. Key players are focusing on enhancing the therapeutics pipeline by developing efficient and safe drugs.

Human Microbiome Market Leaders

DuPont
Seres Therapeutics
Second Genome
Synthetic Biologics Inc.
Axial Biotherapeutics, Inc.

*Disclaimer: Major Players sorted in no particular order